F. Hoffmann-La Roche Ltd - Company Profile
Powered by 
All the sales intelligence you need on F. Hoffmann-La Roche Ltd in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how F. Hoffmann-La Roche Ltd fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with F. Hoffmann-La Roche Ltd.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Business Description
F. Hoffmann-La Roche Ltd (Roche), a subsidiary of Roche Holding AG, develops novel medicines that improve the standard of care in infectious diseases, cancer, immunology, ophthalmology and neuroscience. It also specializes in in vitro diagnostics, tissue-based cancer diagnostics, and diabetes management.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
R&D Overview
Roche is committed to advancing healthcare through innovative research and development across multiple critical areas. The company focuses on oncology, neuroscience, rare diseases, ophthalmology, inflammatory bowel diseases, respiratory, and women's health. Its efforts span from rigorous cancer biology research in oncology to pioneering therapies in ophthalmology aimed at preventing vision loss. In neuroscience, Roche pushes scientific boundaries to tackle complex neurological challenges. Additionally, the company focuses on addressing unmet needs in rare diseases and inflammatory bowel diseases, striving to improve outcomes for patients with severe respiratory conditions. The company develops cutting-edge solutions in diagnostics, including personalized diabetes management, innovative cardiometabolic disease diagnostics, and solutions for infectious diseases. It also focuses on hematology and women's health diagnostics, enhancing healthcare decision-making and patient care across the diagnostic journey. The company leverages synergies between pharma and diagnostics, uniquely positioned to integrate therapeutic development with diagnostic capabilities, enhancing clinical success and patient outcomes through comprehensive healthcare solutions. Through its pharmaceuticals research and early development (pRED) and Genentech research and early development (gRED), the company develops new technologies and drugs. It has R&D centers in Switzerland, the US, the UK, Germany and China. The company collaborated with investigators from universities in Europe, the US, Asia and Australia.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer